Blog

REDDSTAR Mid-Project Report

The REDDSTAR Mid-Project Report has been published, and is also available here. —————————————————————————————— REDDSTAR Repair of Diabetic Damage by Stromal Cell Administration Mid-Project Report - .pdf version Description of work performed to date The central objective during the initial 18 months of REDDSTAR has been to assess the effect of MSC (mesenchymal stem cell) therapy in each of six…

NUI Galway Public Forum on Diabetes

On Tuesday, 9 September NUI Galway will host a public forum on Diabetes, delving into what research is doing to help advance treatments for complications of Type 2 diabetes. ‘Diabetes- It’s Complicated’ will take place in Room 243, Áras Moyola from 6.30-8.30pm. This free event is organised as part of the EU-funded project Repair of…

Meet Steve Elliman, Head of Research at Orbsen Therapeutics

REDDSTAR Dissemination Officer Danielle Nicholson interviewed Steve for a story which recently appeared on the EuroStemCell website.   What do you think is the most misunderstood concept or idea surrounding stem cell research? The broadest, most misunderstood concept is that all stem cell research falls under the umbrella of embryonic stem cell research. This is a…

Evaluation of preclinical studies performed within the REDDSTAR Project

Evaluation of preclinical studies performed within the REDDSTAR Project: Treatment of Diabetic Ulcers with CD362+SSC (Cyndacel-M) recommended for clinical phase 1b study. On 22nd April 2014, the REDDSTAR consortium gathered in Paris to evaluate the project’s preclinical studies on SSC treatment of diabetic complications. The central objective during the initial 18 months of the REDDSTAR…

REDDSTAR shines at the ISCT 2014 Paris conference

  REDDSTAR Co-ordinator, Professor of Medicine Tim O’Brien NUI Galway, and Orbsen Therapeutics’ Head of Research, Dr. Steve Elliman took part in an interactive workshop during the International Society for Cellular Therapy (ISCT) 20th Anniversary meeting held in France at Le Palais des Congrès de Paris. The workshop showcased ‘EU-funded projects on Cellular Therapies’ and…

Debating Science Issues: Communicating Biomedical Science and Health through Dialogue

The Royal College of Surgeons in Ireland (RCSI) played host to the 2014 Debating Science Issues (DSI) All-Ireland Finals last Thursday. St Joseph’s Secondary CBS, Fairview from Dublin emerged as eventual winners of the competition. Manolito Aviles and Alexander Fay, the speakers from the winning school, are pictured left with DSI All-Ireland coordinator Danielle Nicholson.  Colaiste…

REDDSTAR features on Portuguese television news

Principal Investigator, Professor Isaura Tavares and her REDDSTAR work on diabetic neuropathy recently featured in two Portuguese television news programs. O trabalho da Investigadora Principal, Professora Isaura Tavares, na área da neuropatia diabética e no âmbito do projeto REDDSTAR foi recentemente divulgado em dois canais televisivos portugueses.  

All-Ireland Finals of Debating Science Issues

The All-Ireland Finals of Debating Science Issues (DSI) will take place on 27 March 2014 at the Royal College of Surgeons in Ireland, 123 St. Stephen’s Green, Dublin 1.  Through a process of single elimination, the field of 32 secondary schools narrowed to just four representing all four provinces in Ireland.  Co-ordinated by REDDSTAR’s Dissemination…

Orbsen Therapeutics introduces REDDSTAR FP7 at the Irish Cytometry Society 2014 Annual Meeting

Orbsen Scientist, Dr. Lisa O’ Flynn delivered a presentation entitled ‘CD362: a functional marker for MSC isolation & therapeutic differentiation’ as part of the Irish Cytometry Society’s annual meeting in Astra Hall, University College Dublin on 26 February  2014. Dr. O’ Flynn’s talk provided a succinct background of CD362 and highlighted the importance of CD362…

REDDSTAR presents at International Society of Cellular Therapy 2014 conference

REDDSTAR’s mid-project meeting has been planned for 22 April 2014 to precede the International Society of Cellular Therapy (ISCT) 20th Anniversary meeting which will be held in Paris, France 23-26 April 2014. In conjunction with the 18 month plenary meeting, REDDSTAR Co-ordinator Professor of Medicine Tim O’Brien NUI Galway, and Orbsen Therapeutics’ Head of Research,…

Menu